Mars announced it plans a €130 million ($141.3M) investment in its operations in France in 2024, the same amount as last year. More than half of it, €67.6 million ($73.3M), will be dedicated to enhancing the capabilities of its pet business.
A total of €38 million ($41.3M) will be invested in Royal Canin’s production at the Aimargues production site in Gard, 40 km from Montpellier in the south of France.
GlobalPETS learned that the funds will be used to renovate kennels and the building, install solar panels, increase raw material storage capacity and extend Mars’ central research and development (R&D) laboratory and offices.
More investment
An additional €20 million ($21.7M) budget will be dedicated to installing new food production lines and modernizing existing production platforms in the facility in Saint-Denis-de-l’Hôtel in Loiret, 150 km south of Paris.
The plant, which manufactures Pedigree and Whiskas products, received an investment of €120 million ($130M) over 2 years.
Mars France has invested more than €400 million ($434.9M) over the past 5 years. The pet portfolio is expected to account for 60% of total sales nationwide.
The latest articles
CULT Food starts cultivated pet food regulatory race in the US
A subsidiary of the Canadian cell-based firm is to file a feeding trial to seek approval to sell the product in the country.
Purina witnessing a deceleration, admits Nestlé’s CFO
The multinational’s pet portfolio increased sales in the first half of 2024. GlobalPETS dives into the latest earnings.
American biotech companies receive $36 million in investments
California-based NovoNutrients and Digestiva to scale their footprints in alternative protein.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.